Aarti Pharmalabs Limited (NSE:AARTIPHARM)

Aarti Pharmalabs Revenue

In the fiscal year ending March 31, 2026, Aarti Pharmalabs had annual revenue of 18.19B INR, down -13.98%. Aarti Pharmalabs had revenue of 5.83B in the quarter ending March 31, 2026, with 3.35% growth.

• Revenue: 18.19B
• Revenue Growth: -13.98%
• P/S Ratio: 3.10
• Revenue / Employee: 8.42M
• Employees: 2,162
• Market Cap: 56.42B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	18.19B	-2.96B	-13.98%
Mar 31, 2025	21.15B	2.62B	14.17%
Mar 31, 2024	18.53B	-926.24M	-4.76%
Mar 31, 2023	19.45B	7.45B	62.11%
Mar 31, 2022	12.00B	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error